Skip to main content

Periodic Breathing

0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

ResMed
ResMedSAN DIEGO, CA
2 programs
Adaptive Servo-controlled VentilationN/A1 trial
Modified Adaptive Servoventilation DeviceN/A1 trial
Active Trials
NCT01037439Completed20Est. Dec 2009
NCT01405313Completed21Est. Sep 2011

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
ResMedModified Adaptive Servoventilation Device
ResMedAdaptive Servo-controlled Ventilation

Clinical Trials (2)

Total enrollment: 41 patients across 2 trials

NCT01405313ResMedModified Adaptive Servoventilation Device

Modified Adaptive Servoventilation (ASV) Compared to Conventional ASV

Start: Jul 2011Est. completion: Sep 201121 patients
N/ACompleted
NCT01037439ResMedAdaptive Servo-controlled Ventilation

Comparison of Modified With Conventional Adaptive Servoventilation Processes

Start: Jun 2008Est. completion: Dec 200920 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.